Search - tctmd.com

Displaying 61 - 80 of 138

Sort: Relevancy | Date

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

Presentation TVT 2019

The Utility of Transcatheter Aortic Valve Replacement in Very Low-Gradient Severe Aortic Stenosis

Presenter: Giorgio Medranda

June 14, 2019

Presentation TVT 2019

Diastolic Dysfunction and Clinical Outcomes in Non-Typical Aortic Stenosis Subtypes After Transcatheter Aortic Valve Replacement

Presenter: Rashad Belin

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases

Presenter: J. Matthew Brennan

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

Treatment of Severe Pulmonary Insufficiency in a Patient With Tetralogy of Fallot and Left Pulmonary Artery Stenosis With an Edwards Sapien3 Valve

Presenter: Isla McClelland

June 13, 2019

Presentation TVT 2019

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard Herrmann

June 13, 2019

Presentation TVT 2019

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Presenter: Axel Linke

June 13, 2019

Advertisement

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Device Explants After TAVR Rare but Risky

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

The Utility of Transcatheter Aortic Valve Replacement in Very Low-Gradient Severe Aortic Stenosis

Diastolic Dysfunction and Clinical Outcomes in Non-Typical Aortic Stenosis Subtypes After Transcatheter Aortic Valve Replacement

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Disparities in the Treatment of Aortic Stenosis: Race, Gender, and Referring Physician Biases

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Treatment of Severe Pulmonary Insufficiency in a Patient With Tetralogy of Fallot and Left Pulmonary Artery Stenosis With an Edwards Sapien3 Valve

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content